India Single Cell Sequencing Market (2025-2030)
The India Single Cell Sequencing Market was valued at $36.3 Million in 2025 and projected to reach to $64.9 Million by 2030, representing a compound annual growth rate of 12.3%. India's single cell sequencing market is poised for sustained growth driven by increasing government support for genomic research, rising healthcare expenditure, and growing awareness of precision medicine benefits among clinicians and researchers.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Single Cell Sequencing Market Trends and Insights
- This expansion reflects India's increasing investment in genomic research infrastructure and rising adoption of advanced sequencing technologies across academic and clinical institutions.
- India is emerging as a key hub for precision medicine and personalized healthcare, driving demand for single cell analysis tools that enable detailed cellular characterization. The Indian market benefits from a growing biotechnology sector, expanding research collaborations, and government initiatives supporting genomic research.
- India's cost-competitive advantage in research and development attracts both domestic and international players to establish operations in the country.
- Between 2025 and 2030, India is expected to witness accelerated adoption of single cell sequencing in cancer research, immunology, and developmental biology, supported by increasing funding and institutional capacity building. India's position within the Asia Pacific region positions it as a significant growth market for single cell sequencing technologies.
- The country's large patient population and rising healthcare expenditure create substantial opportunities for market expansion, while India continues to strengthen its scientific workforce and research capabilities in genomic sciences..
Key Market Statistics
- CAGR (2025-2030) 12.3% CAGR
- Market Size, 2025 ~USD 36.3 Million
- Forecast, 2030 ~USD 64.9 Million
- Country India
India Single Cell Sequencing Market Overview
Market Valuation Growth :
India's single cell sequencing market is valued at $36.3 million in 2025 and is projected to reach $64.9 million by 2030, representing a robust 12.3% CAGR, closely aligned with global growth trends.
Genomic Research Infrastructure Expansion :
India is witnessing significant investments in genomic research infrastructure, with government initiatives and private sector funding driving the establishment of advanced sequencing facilities across major research institutions and hospitals.
Precision Medicine Adoption :
Indian academic and clinical institutions are increasingly adopting single cell sequencing technologies for precision medicine applications, enabling personalized treatment strategies and advancing cancer research and immunology studies.
Emerging Hub for Genomic Innovation :
India is positioning itself as a key hub for genomic research and precision medicine in Asia, attracting international collaborations and investments while developing indigenous expertise in single cell analysis technologies.
India Single Cell Sequencing Market Dynamics
- The market expansion is supported by collaborations between academic institutions, government research organizations, and private biotech companies establishing state-of-the-art sequencing centers across major cities. The forecast period through 2030 will witness accelerated adoption as costs decline, technical expertise increases, and applications expand beyond research into clinical diagnostics and therapeutic development.
- India's large patient population, coupled with growing investment in healthcare infrastructure and digital health integration, creates significant opportunities for single cell sequencing adoption in oncology, immunology, and infectious disease research..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- India's single cell sequencing market is valued at $36.3 million in 2025 and is forecast to grow to $64.9 million by 2030, representing a 12.3% CAGR.
- India's cost-competitive research environment and growing biotechnology sector are attracting international investment and driving adoption of advanced sequencing technologies.
- Government initiatives and increased funding for genomic research are accelerating India's development as a precision medicine hub within Asia Pacific.
- India's large patient population and expanding healthcare infrastructure create significant opportunities for single cell sequencing applications in cancer, immunology, and developmental biology research.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
India Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 3.84 | 4.39 | 4.77 | 5.35 | 6.11 | 7.13 | 8.52 | 10.41 | 16.9 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 3.52 | 4.05 | 4.44 | 5.01 | 5.76 | 6.76 | 8.14 | 10.01 | 17.7 |
| HOSPITALS & CLINICAL LABORATORIES | 2.85 | 3.2 | 3.42 | 3.77 | 4.22 | 4.84 | 5.67 | 6.8 | 14.7 |
| TOTAL | 10.21 | 11.64 | 12.63 | 14.13 | 16.1 | 18.73 | 22.33 | 27.22 | 16.6 |
INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 14.6 | 14.8 | 15.2 | 16.3 | 18 | 20.3 | 23.4 | 27.5 | 12.5 |
| CROS | 3 | 3 | 3.1 | 3.2 | 3.5 | 3.9 | 4.5 | 5.2 | 10.9 |
| HOSPITALS & CLINICAL LABORATORIES | 6.8 | 6.8 | 7 | 7.4 | 8.1 | 9.1 | 10.4 | 12.1 | 11.6 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 10.5 | 10.7 | 11 | 11.8 | 13.1 | 14.8 | 17.2 | 20.2 | 12.9 |
| TOTAL | 34.9 | 35.3 | 36.3 | 38.7 | 42.6 | 48.1 | 55.4 | 64.9 | 12.3 |
Target Audience
- Biotech & Sequencing Companies : Equipment manufacturers and service providers need India-specific market data to identify growth opportunities, plan product launches, establish partnerships with Indian institutions, and capture market share in this high-growth segment.
- Healthcare & Research Institutions : Indian hospitals, research centers, and academic institutions require market intelligence to benchmark their capabilities, justify investments in single cell sequencing infrastructure, and align with national precision medicine initiatives.
- Investment & Private Equity Firms : Investors evaluating opportunities in Indian biotech and genomics need detailed market analysis to assess growth potential, identify promising startups and institutions, and make informed funding decisions in this emerging sector.
- Government & Policy Makers : Indian government agencies and health policy makers need market data to design genomic research policies, allocate funding for infrastructure development, and establish regulatory frameworks supporting precision medicine adoption.
- Pharmaceutical & Diagnostic Companies : Pharma and diagnostic firms operating in India require market insights to develop companion diagnostics, integrate single cell sequencing into clinical workflows, and support precision medicine-based drug development strategies.
Reasons to Buy this Report
- India-Specific Market Sizing : Access precise valuation data for India's single cell sequencing market with verified 2025 baseline ($36.3M) and 2030 forecast ($64.9M), enabling accurate business planning and investment decisions tailored to the Indian market.
- Growth Trajectory Analysis : Understand India's 12.3% CAGR performance relative to global 12.2% growth, identifying unique market dynamics, regional advantages, and competitive positioning opportunities specific to the Indian healthcare and research landscape.
- Infrastructure & Investment Insights : Gain detailed intelligence on India's genomic research infrastructure expansion, government initiatives, institutional investments, and private sector developments driving market growth and technology adoption across the country.
- Clinical & Research Adoption Trends : Identify adoption patterns across Indian academic institutions, hospitals, and clinical centers, understanding how precision medicine applications and single cell sequencing are being integrated into Indian healthcare delivery systems.
- Strategic Market Entry Planning : Develop informed market entry and expansion strategies with comprehensive India-focused data on competitive landscape, regulatory environment, key stakeholders, and growth opportunities in this emerging genomic research hub.
Frequently asked questions
What is the current market size of single cell sequencing in India?
India's single cell sequencing market was valued at $36.3 million in 2025 and is expected to grow at a 12.3% CAGR through 2030.
What is the projected market size for single cell sequencing in India by 2030?
India's single cell sequencing market is projected to reach $64.9 million by 2030, driven by increased adoption in research and clinical applications.
What factors are driving growth in India's single cell sequencing market?
Growth in India is driven by government support for genomic research, expanding biotechnology infrastructure, cost-competitive advantages, and rising demand for precision medicine applications.
Which research areas are adopting single cell sequencing most rapidly in India?
India is seeing accelerated adoption in cancer research, immunology, and developmental biology, supported by increasing institutional funding and research collaborations.
How does India's single cell sequencing market compare to other Asia Pacific countries?
India represents a significant growth market within Asia Pacific, leveraging its large population, cost advantages, and expanding research capabilities to attract both domestic and international investment.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
